McCormick & Co. (MKC) Has Leaped To A New High On Strong Q2 Earnings
Markets2018-06-28
17 Views
McCormick & Co. (MKC) reported second quarter EPS of $1.02 Thursday morning, up from $0.82 a year ago. Street expectations were for EPS of $0.93.
Source: RTTNews
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis
